Mario E Lacouture

Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0.

M. Lacouture, M. Anadkat, E. Olsen, 2012, Journal of the American Academy of Dermatology.

Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis.

Antonio DeRosa, Daniel E Spratt, Antonio P. DeRosa, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.

Afsaneh Barzi, Katrina Pedersen, Jeannine S McCune, 2019, The Lancet. Oncology.

Prophylaxis and treatment of dermatologic adverse events from epidermal growth factor receptor inhibitors

M. Lacouture, M. Anadkat, Y. Balagula, 2011, Current opinion in oncology.